For Wound Care Specialists in Eugene, OR

What I’d check before adding wound care specialists here

Eugene is a city under 250k (176,654 Census). CDC PLACES (2023, crude) estimates 9.4% of adults in Eugene have diagnosed diabetes — 2.6 points below the U.S. 12% figure. Adult arthritis here is 26% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.

Cash PRP and Medicare CTPs in the same hallway

• CDC PLACES (2023, crude) estimates 9.4% of adults in Eugene have diagnosed diabetes — 2.6 points below the U.S. 12% figure. Adult obesity in Eugene is 34% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JF review. Product is the last step, not the first.
• Oregon is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).
• Non-opioid pain pathways (PRP, orthobiologics) still need diagnosis codes that justify the procedure. Oregon payers will not treat “patient prefers regenerative” as medical necessity.

Uninsured mix and Medicare CTPs in the same building

JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Eugene is 9.4% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic